along with giving DGEN royalty rights on top of the 25 million for any drugs commercialized from the data, and the mice were extra. The major deal that mgmt pulled off to pull the company out of bk was a multi-million deal with the NIH and the Wellcome-Trust whereby mice and the database were made available to academic institutions on a royalty free basis - but royalty rights were retained for any commercial development of any academic development. Run Deltagen through the US Patent Office database - they hold dozens. Hundreds more were in the application process pipeline but had to be abandoned as the legal fees for patent perfection were not sustainable - another proper call by mgmt. All to say, this company has been an absolute steal at a nickel.
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM